179 Am J Health-Syst Pharm—Vol 62  Jan 15, 2005REPORTS Type 2 diabetes mellitus Figure 3.  Postprandial hormonal response and gastric emptying ( n = 8). Mean ± S.E. (bars) plasma insulin  (A) and glucagon  (B) concentra- tions in study A. In (B), exenatide-treated groups had significantly lower plasma glucagon AUC0–3 hr compared with the placebo group ( p ≤ 0.0006). (C) Mean ± S.E. (bars) plasma acetaminophen concentrations in study B. Study drug was administered at 0 hour. Enteral nutrient formulation (7 kcal/kg) and acetaminophen (20 mg/kg) were given 15 minutes after administration of the study drug. 150 125 100 75 50 0 012345678Insulin ( µµµµµU/mL) Time (hr)A Study Drug 25 175 150 125 100 75 0Glucagon (ng/L)B Study Drug 50 25 –0.5 0.0 0.5 1.0 1.5 2.0 2.5 3.0Time (hr) Time (hr)–0.5 0.0 1.0 1.5 2.016 14 1210 8 0Acetaminophen ( µµµµµg/mL)C Study Drug 26 4 0.5Placebo Exenatide 0.1 µg/kg Exenatide 0.2 µg/kg Exenatide 0.3 µg/kg Exenatide 0.4 µg/kg Placebo Exenatide 0.1 µg/kg